DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prednisone (Prednisone) - Anaemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Anaemia (98)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisone where reactions include anaemia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 98   Next >>

Possible Prednisone side effects in male

Reported by a physician from Romania on 2012-08-21

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Cardio-Respiratory Arrest, Anaemia, Dehydration

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Abiraterone Acetate
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2011-12-16
    End date: 2012-06-16

Abiraterone Acetate
    Administration route: Oral

Prednisone
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2011-12-16
    End date: 2012-06-16



Possible Prednisone side effects in female

Reported by a physician from United States on 2012-08-21

Patient: female, weighing 56.3 kg (123.9 pounds)

Reactions: Contusion, Pneumonia, Goitre, Anaemia, Hereditary Angioedema, Intervertebral Disc Degeneration, Toxicity To Various Agents

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cinryze
    Indication: Hereditary Angioedema
    Start date: 2011-02-11

Prednisone
    Dosage: unknown
    Indication: Product Used FOR Unknown Indication

Warfarin Sodium
    Dosage: unknown
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Albuterol; Dilaudid; Fioricet; Nortriptyline; Ibuprofen; Tylenol; Colace; Miralax; Metamucil-2; Probiotics; Dilantin; Oxycodone HCL; Diphenhydramine Hydrochloride; Phenergan HCL; Ferrous Gluconate; Zofran; Dulcolax; Danazol; Prevacid; Trazodone Hydrochloride; Epipen; Docusate; Fosamax; Spiriva; Magnesium Citrate; Asmanex Twisthaler; Atenolol; Nasonex; Soma; Enema



Possible Prednisone side effects in female

Reported by a physician from Netherlands on 2012-08-17

Patient: female, weighing 46.0 kg (101.2 pounds)

Reactions: Anaemia, Circulatory Collapse

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-10-05

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-10-05

Filgrastim
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-10-06

Mabthera
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-10-06

Prednisone
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-10-05



Possible Prednisone side effects in

Reported by a consumer/non-health professional from United States on 2012-08-07

Patient:

Reactions: Foot Deformity, Femur Fracture, Pruritus, Hyperkeratosis, Tinnitus, Contusion, Tachycardia, Headache, Cardiac Disorder, Herpes Zoster, Arthropathy, Palpitations, Postmenopausal Haemorrhage, Tympanic Membrane Perforation, Joint Effusion, LOW Turnover Osteopathy, Back Pain, Cellulitis, Cerumen Impaction, Anaemia, Ear Disorder, Bursitis, Haemorrhagic Anaemia, Gastric Disorder, Flushing, Osteonecrosis, Benign Neoplasm of Skin, Dysphonia, Systemic Lupus Erythematosus, Essential Hypertension, Adverse Drug Reaction, Fall, Nail Infection, Liver Function Test Abnormal, Dermatomyositis, Gastrooesophageal Reflux Disease, Exostosis, Soft Tissue Injury, Urinary Tract Infection, Deafness Neurosensory, Arrhythmia, Carotid Artery Stenosis, Osteoarthritis, Arthralgia, Vertigo, Arthritis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Alendronate Sodium
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2008-02-01
    End date: 2008-01-01

Alendronate Sodium
    Indication: Osteoporosis Prophylaxis

Fosamax
    Administration route: Oral
    Start date: 2008-02-01
    End date: 2008-01-01

Fosamax
    Indication: Osteoporosis Prophylaxis

Fosamax
    Dosage: 70 mg, qw
    Administration route: Oral
    Indication: Osteopenia
    Start date: 2001-05-08
    End date: 2008-07-01

Fosamax
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 1998-01-01
    End date: 2001-04-01

Prednisone
    Dosage: unk
    Indication: Dermatomyositis
    Start date: 2002-12-01
    End date: 2008-02-01

Reclast
    Dosage: 5/100 ml
    Indication: Osteoporosis

Other drugs received by patient: Esomeprazole



Possible Prednisone side effects in female

Reported by a physician from Poland on 2012-08-02

Patient: female, weighing 58.0 kg (127.6 pounds)

Reactions: Retroperitoneal Mass, Vomiting, Nausea, Anaemia, Nephropathy Toxic, Folate Deficiency, Iron Deficiency, Herpes Zoster, Vitamin B12 Increased, Asthenia, Beta 2 Microglobulin Increased, Leukopenia

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Lymphoma
    Start date: 2011-06-22
    End date: 2011-10-27

Doxorubicin Hydrochloride
    Indication: Lymphoma
    Start date: 2011-06-22
    End date: 2011-10-27

Prednisone
    Administration route: Oral
    Indication: Lymphoma
    Start date: 2011-06-22
    End date: 2011-10-27

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-06-22
    End date: 2011-10-27

Vincristine
    Indication: Lymphoma
    Start date: 2011-06-22
    End date: 2011-10-27

Other drugs received by patient: Heviran; Tamoxifen Citrate



Possible Prednisone side effects in 46 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30

Patient: 46 year old female

Reactions: Pain in Extremity, Anaemia, Pyrexia, Pallor, Stem Cell Transplant, Pulmonary Haemorrhage, Zygomycosis, Skin Discolouration, Blood Culture Positive, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Asthenia, Hepatosplenomegaly, Candidiasis, Cough

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Carmustine

Cyclophosphamide
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Cytarabine

Cytarabine
    Dosage: 1.5 g/d/m2 (1 cycle)

Doxorubicin Hydrochloride
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide

Idarubicin HCL
    Dosage: 12 mg/d/m2 (1 cycle)

Melphalan Hydrochloride

Oncovin
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab

Vorinostat
    Dosage: 1 cycle
    Administration route: Oral



Possible Prednisone side effects in 46 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30

Patient: 46 year old female

Reactions: Pain in Extremity, Unresponsive To Stimuli, Anaemia, Pallor, Pulmonary Haemorrhage, Zygomycosis, Skin Discolouration, Diarrhoea Haemorrhagic, Blood Culture Positive, Small Intestinal Haemorrhage, Asthenia, Apnoea, Hepatosplenomegaly, Candidiasis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Carmustine

Cyclophosphamide
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Cytarabine

Cytarabine
    Dosage: 1.5 g/d/m2 (1 cycle)

Doxorubicin Hydrochloride
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide

Idarubicin HCL
    Dosage: 12 mg/d/m2 (1 cycle)

Melphalan Hydrochloride

Oncovin
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab

Vorinostat
    Dosage: 1 cycle
    Administration route: Oral



Possible Prednisone side effects in female

Reported by a physician from United Kingdom on 2012-07-27

Patient: female, weighing 53.0 kg (116.6 pounds)

Reactions: Anaemia, Neutropenia, Hypokalaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-23

Doxorubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-23

Furosemide

Prednisone
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-23

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-23



Possible Prednisone side effects in 46 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27

Patient: 46 year old female

Reactions: Pancreatic Infarction, Unresponsive To Stimuli, Myelodysplastic Syndrome, Pyrexia, Pallor, Cerebral Haemorrhage, Skin Discolouration, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Apnoea, Thrombocytopenia, Cough, Candidiasis, Hepatosplenomegaly, Dyspnoea, Pain in Extremity, Anaemia, Pulmonary Haemorrhage, Zygomycosis, Diarrhoea, Hemisensory Neglect, Lung Infiltration, Asthenia, Hepatic Infarction

Adverse event resulted in: death

Drug(s) suspected as cause:
Carmustine
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Cytarabine
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide
    Indication: Diffuse Large B-Cell Lymphoma

Idarubicin HCL
    Dosage: 12 mg/m2, unk
    Indication: Myelodysplastic Syndrome

Oncovin
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma

Suberoylanilide Hydroxamic Acid
    Dosage: 500 mg, tid
    Administration route: Oral
    Indication: Myelodysplastic Syndrome

Other drugs received by patient: Radiotherapy



Possible Prednisone side effects in

Reported by a consumer/non-health professional from United States on 2012-07-26

Patient:

Reactions: Foot Deformity, Tinnitus, Femur Fracture, Pruritus, Contusion, Hyperkeratosis, Tachycardia, Headache, Herpes Zoster, Cardiac Disorder, Arthropathy, Palpitations, Joint Effusion, Tympanic Membrane Perforation, LOW Turnover Osteopathy, Back Pain, Cellulitis, Cerumen Impaction, Anaemia, Ear Disorder, Haemorrhagic Anaemia, Bursitis, Gastric Disorder, Flushing, Osteonecrosis, Dysphonia, Benign Neoplasm of Skin, Systemic Lupus Erythematosus, Essential Hypertension, Adverse Drug Reaction, Nail Infection, Fall, Liver Function Test Abnormal, Dermatomyositis, Gastrooesophageal Reflux Disease, Exostosis, Soft Tissue Injury, Deafness Neurosensory, Arrhythmia, Carotid Artery Stenosis, Osteoarthritis, Arthralgia, Vertigo, Arthritis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Alendronate Sodium
    Indication: Osteoporosis Prophylaxis

Alendronate Sodium
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2008-02-01
    End date: 2008-01-01

Fosamax
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 1998-01-01
    End date: 2001-04-01

Fosamax
    Dosage: 70 mg, qw
    Administration route: Oral
    Indication: Osteopenia
    Start date: 2001-05-08
    End date: 2008-07-01

Fosamax
    Administration route: Oral
    Start date: 2008-02-01
    End date: 2008-01-01

Fosamax
    Indication: Osteoporosis Prophylaxis

Prednisone
    Dosage: unk
    Indication: Dermatomyositis
    Start date: 2002-12-01
    End date: 2008-02-01

Reclast
    Dosage: 5/100 ml
    Indication: Osteoporosis

Other drugs received by patient: Esomeprazole



Possible Prednisone side effects in

Reported by a physician from Italy on 2012-07-20

Patient:

Reactions: Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Diffuse Large B-Cell Lymphoma Recurrent, Mucosal Inflammation, Neurotoxicity, Sepsis, Adverse Event, Cardiotoxicity, Neutropenia, Thrombocytopenia, Diffuse Large B-Cell Lymphoma, Lymphoma, Septic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 750 mg/m2 on day 1 for chop and 750 mg/m2 on day 2 for r-chop
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Dosage: 50 mg/m2 on day 1 for chop and 50 mg/m2 on day 2 for r-chop
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Dosage: 100 mg on days 1-5 for chop and r-chop
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: 375 mg/m2 on day 1 for r-chop
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Dosage: 1.4 mg/m2 on day 1 for chop and 1.4 mg/m2 on day 2 for r-chop upto a maximum dose of 2 mg
    Indication: Diffuse Large B-Cell Lymphoma

Other drugs received by patient: Neupogen



Possible Prednisone side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-07-19

Patient: 68 year old female

Reactions: Enterocolitis Haemorrhagic, Gastrointestinal Haemorrhage, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clarithromycin
    Administration route: Oral
    Indication: Pneumonia
    Start date: 2012-03-23
    End date: 2012-04-05

Escitalopram
    Indication: Product Used FOR Unknown Indication

Ibuprofen Tablets
    Administration route: Oral
    Indication: Back Pain
    Start date: 2012-03-01
    End date: 2012-04-04

Methotrexate
    Administration route: Oral
    Indication: Psoriasis
    Start date: 2005-08-01
    End date: 2012-04-04

Prednisone
    Administration route: Oral
    Indication: Psoriasis
    Start date: 2005-08-01

Rocephin
    Indication: Pneumonia
    Start date: 2012-03-23
    End date: 2012-04-05

Other drugs received by patient: Calcimagon D3; Ramipril; Pantoprazole



Possible Prednisone side effects in 65 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-19

Patient: 65 year old male, weighing 100.0 kg (220.0 pounds)

Reactions: Carotid Artery Stenosis, Dyspnoea, Dilatation Ventricular, Anaemia, Thrombotic Thrombocytopenic Purpura, Transient Ischaemic Attack

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: 150 microgram
    Start date: 2012-03-21
    End date: 2012-04-11

Docetaxel
    Dosage: 150 microgram
    Indication: Prostate Cancer
    Start date: 2011-08-03
    End date: 2011-08-23

Lenalidomide
    Dosage: 25 milligram
    Administration route: Oral
    End date: 2011-10-01

Lenalidomide
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Prostate Cancer
    Start date: 2011-08-03
    End date: 2011-11-25

Prednisone
    Dosage: 20 milligram
    Start date: 2012-03-21
    End date: 2012-04-11

Prednisone
    Dosage: 20 milligram
    Indication: Prostate Cancer
    Start date: 2011-08-03
    End date: 2011-08-23

Other drugs received by patient: Vitamin B-12; Simvastatin; Amlodipine; Aspirin; Valsartan / Provas; Lhrh Analogon; Dexamethasone; Zometa



Possible Prednisone side effects in male

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-07-17

Patient: male

Reactions: Escherichia Urinary Tract Infection, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: 14 milligram
    Administration route: Oral
    Start date: 2012-01-19
    End date: 2012-01-22

Melphalan Hydrochloride
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-11-23

Prednisone
    Dosage: 160 milligram
    Administration route: Oral
    Start date: 2012-01-19
    End date: 2012-01-22

Prednisone
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-11-23

Thalidomide
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-01-19
    End date: 2012-01-29

Thalidomide
    Administration route: Oral
    Start date: 2011-11-23

Thalidomide
    Administration route: Oral
    Start date: 2012-02-07

Other drugs received by patient: Oxycontin; Carbasalaat Calcium; Oxycodone HCL; Acetaminophen; Simvastatin; Pantoprazole; Vesicare; Klyx Enema; Diclofenac; Polyethylene Glycol



Possible Prednisone side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-10

Patient: female

Reactions: Enterocolitis Haemorrhagic, Gastrointestinal Haemorrhage, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clarithromycin
    Dosage: 1000 mg
    Administration route: Oral
    Indication: Pneumonia
    Start date: 2012-03-23
    End date: 2012-04-05

Escitalopram
    Dosage: 10 mg
    Administration route: Oral

Fragmin
    Dosage: 5000 iu
    Indication: Prophylaxis
    Start date: 2012-03-01
    End date: 2012-04-04

Ibruprofen
    Administration route: Oral
    Indication: Back Pain
    Start date: 2012-03-01
    End date: 2012-04-04

Methotrexate
    Administration route: Oral
    Indication: Psoriasis
    Start date: 2005-08-01
    End date: 2012-04-04

Prednisone
    Dosage: 10 mg
    Administration route: Oral
    Indication: Psoriasis
    Start date: 2005-08-01

Rocephin
    Dosage: 2000 mg
    Indication: Pneumonia
    Start date: 2012-03-23
    End date: 2012-04-05

Other drugs received by patient: Pantoprazole; Ramipril; Calcimagon D3



Possible Prednisone side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-07-10

Patient: 68 year old female

Reactions: Enterocolitis Haemorrhagic, Gastrointestinal Haemorrhage, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clarithromycin
    Administration route: Oral
    Indication: Pneumonia
    Start date: 2012-03-23
    End date: 2012-04-05

Escitalopram
    Indication: Product Used FOR Unknown Indication

Ibuprofen Tablets
    Administration route: Oral
    Indication: Back Pain
    Start date: 2012-03-01
    End date: 2012-04-04

Methotrexate
    Administration route: Oral
    Indication: Psoriasis
    Start date: 2005-08-01
    End date: 2012-04-04

Prednisone
    Administration route: Oral
    Indication: Psoriasis
    Start date: 2005-08-01

Rocephin
    Indication: Pneumonia
    Start date: 2012-03-23
    End date: 2012-04-05

Other drugs received by patient: Ramipril; Pantoprazole; Calcimagon D3



Possible Prednisone side effects in female

Reported by a consumer/non-health professional from Germany on 2012-07-06

Patient: female, weighing 70.0 kg (154.0 pounds)

Reactions: B-Cell Lymphoma, Anaemia, Urinary Incontinence, Abnormal Behaviour, Pulmonary Embolism, Cognitive Disorder, Pyrexia, Fall, Peripheral Sensory Neuropathy, Post Transplant Lymphoproliferative Disorder, Klebsiella Infection, Cytokine Release Syndrome, Cytomegalovirus Infection, Neutrophil Toxic Granulation Present, Traumatic Haematoma, Deep Vein Thrombosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, bid
    Start date: 2009-07-23

Campath
    Dosage: 20 mg, qd
    Start date: 2009-07-07

Campath
    Dosage: 30 mg, qd
    Start date: 2009-08-06
    End date: 2009-08-06

Campath
    Dosage: 30 mg, qd
    Start date: 2009-09-11
    End date: 2009-10-22

Campath
    Dosage: 10 mg, qd
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-07-23

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-08-20

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-07-21

Cyclophosphamide
    Dosage: 1250 mg, once
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-09-08
    End date: 2009-09-08

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-07-07

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-08-06
    End date: 2009-08-20

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-07-07

Doxorubicin HCL
    Dosage: 80 mg, once
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-07-21

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-08-06
    End date: 2009-08-20

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-09-08
    End date: 2009-09-08

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-07-23

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-08-20

Filgrastim
    Dosage: 3000 iu, unk
    Start date: 2009-07-26
    End date: 2009-08-27

Filgrastim
    Dosage: unk on days 4 through 13 of course 5
    Start date: 2009-08-20

Filgrastim
    Dosage: unk on days 4 through 12 of course 6
    Start date: 2009-09-08

Filgrastim
    Dosage: unk on days 4, 5, 6 of course 1
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Filgrastim
    Dosage: unk on days 4 through 15 of course 2
    Start date: 2009-07-07

Filgrastim
    Dosage: unk on days 4 through 8 and day 13 of course 3
    Start date: 2009-07-23

Filgrastim
    Dosage: unk on days 6 + 7 and days 9 through 12 of course 4
    Start date: 2009-08-06

Filgrastim
    Dosage: 30000 iu, qd
    Start date: 2009-09-11
    End date: 2009-09-19

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-06-23

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-09-11

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-07-07

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-15

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-08-06
    End date: 2009-08-10

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-07-23

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2009-09-08
    End date: 2009-09-08

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-06-23

Vincristine
    Dosage: 1 mg, once
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-15

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-08-20

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-07-23

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-07-07

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-07-21

Vincristine

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-08-06
    End date: 2009-08-20

Other drugs received by patient: Enoxaparin Sodium; Enoxaparin Sodium; Ganciclovir; Metoprolol Tartrate; Trimethoprim + Sulfamethoxazole; Dexamethasone; Antibiotics; Torsemide; Fluticasone Propionate W; Fondaparinux Sodium; Pantoprazole; Ganciclovir; Spiriva



Possible Prednisone side effects in male

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-07-05

Patient: male

Reactions: Escherichia Urinary Tract Infection, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: 14 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-01-19
    End date: 2012-01-22

Prednisone
    Dosage: 160 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-01-19
    End date: 2012-01-22

Thalidomide
    Administration route: Oral
    Start date: 2012-02-07

Thalidomide
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-01-19
    End date: 2012-01-29

Other drugs received by patient: Oxycodone HCL; Diclofenac Sodium; Simvastatin; Pantoprazole; Oxycontin; Acetaminophen; Carbasalaat Calcium



Possible Prednisone side effects in

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-07-05

Patient:

Reactions: Arrhythmia Supraventricular, Gastrointestinal Toxicity, Hypotension, Anaemia, Atrial Fibrillation, Cardiac Disorder, Disease Progression, Death, Neuropathy Peripheral, Cardiac Failure, Embolism, Sepsis, Atrioventricular Block, Neutropenia, Thrombocytopenia, Myocardial Infarction, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.3 milligram/sq. meter
    Indication: Multiple Myeloma
    Start date: 2006-04-01

Bortezomib
    Dosage: 1.3 milligram/sq. meter

Prednisone
    Dosage: 60 milligram/sq. meter
    Indication: Multiple Myeloma
    Start date: 2006-04-01

Thalidomide
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2006-04-01



Possible Prednisone side effects in

Reported by a physician from United States on 2012-07-05

Patient:

Reactions: Nausea, Anaemia, Chills, Constipation, Fatigue, Neuropathy Peripheral, Alopecia, Adverse Event, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Cyclophosphamide

Cyclophosphamide
    Indication: Chronic Lymphocytic Leukaemia

Cyclophosphamide
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Dosage: on day 1
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Dosage: on day 1

Doxorubicin HCL
    Dosage: on day 1
    Indication: Chronic Lymphocytic Leukaemia

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: B-Cell Lymphoma

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia

Prednisone
    Dosage: on days 1-5
    Administration route: Oral

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1
    Indication: B-Cell Lymphoma

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1
    Indication: Chronic Lymphocytic Leukaemia

Rituximab
    Dosage: on day 1

Rituximab
    Dosage: maintenance

Velcade
    Dosage: on days 1 and 8

Velcade
    Dosage: on days 1 and 8
    Indication: Chronic Lymphocytic Leukaemia

Velcade
    Dosage: on days 1 and 8
    Indication: B-Cell Lymphoma



Possible Prednisone side effects in 48 year old male

Reported by a pharmacist from United States on 2012-07-05

Patient: 48 year old male, weighing 97.6 kg (214.7 pounds)

Reactions: Anaemia, Gastric Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone
    Dosage: mg every day po ; 75
    Administration route: Oral
    Indication: Gout
    Start date: 2011-08-16
    End date: 2011-08-26

Prednisone
    Dosage: mg every day po ; 75
    Administration route: Oral
    Indication: Gout
    Start date: 2011-06-10
    End date: 2011-08-23



Possible Prednisone side effects in 69 year old male

Reported by a individual with unspecified qualification from Germany on 2012-07-03

Patient: 69 year old male

Reactions: Anaemia, Febrile Neutropenia, Asthenia, Fall

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma

Mabthera
    Indication: non-Hodgkin's Lymphoma

Prednisone
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Indication: non-Hodgkin's Lymphoma



Possible Prednisone side effects in 80 year old male

Reported by a pharmacist from United States on 2012-06-27

Patient: 80 year old male, weighing 57.3 kg (126.1 pounds)

Reactions: Anaemia, Gastric Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Naproxen
    Dosage: 500 mg bid po
    Administration route: Oral
    Indication: Inflammation
    Start date: 2008-11-17
    End date: 2012-06-19

Naproxen
    Dosage: 500 mg bid po
    Administration route: Oral
    Indication: Pain
    Start date: 2008-11-17
    End date: 2012-06-19

Prednisone
    Dosage: 5 mg every day po
    Administration route: Oral
    Indication: Inflammation
    Start date: 2008-11-05
    End date: 2012-06-19



Possible Prednisone side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25

Patient: male, weighing 108.5 kg (238.7 pounds)

Reactions: Anaemia, Myelodysplastic Syndrome, Thrombocytopenia, Epistaxis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: 24 milligram
    Indication: Multiple Myeloma
    Start date: 2010-08-24
    End date: 2010-08-27

Melphalan Hydrochloride
    Dosage: 24 milligram
    Start date: 2011-01-04
    End date: 2011-01-07

Melphalan Hydrochloride
    Dosage: 24 milligram
    Start date: 2010-10-05
    End date: 2010-10-08

Melphalan Hydrochloride
    Dosage: 4 milligram
    Start date: 2011-08-30
    End date: 2011-09-02

Melphalan Hydrochloride
    Dosage: 6 milligram
    Start date: 2011-05-31
    End date: 2011-06-03

Melphalan Hydrochloride
    Dosage: 6 milligram
    Start date: 2011-07-12
    End date: 2011-07-15

Melphalan Hydrochloride
    Dosage: 24 milligram
    Start date: 2010-11-16
    End date: 2010-11-19

Melphalan Hydrochloride
    Dosage: 14 milligram
    Start date: 2011-02-22
    End date: 2011-02-25

Melphalan Hydrochloride
    Dosage: 14 milligram
    Start date: 2011-04-12
    End date: 2011-04-15

Melphalan Hydrochloride
    Dosage: 4 milligram
    Start date: 2011-10-18
    End date: 2011-10-21

Prednisone
    Dosage: 210 milligram
    Start date: 2011-07-12
    End date: 2011-07-15

Prednisone
    Dosage: 230 milligram
    Indication: Multiple Myeloma
    Start date: 2010-08-24
    End date: 2010-08-27

Prednisone
    Dosage: 215 milligram
    Start date: 2011-05-31
    End date: 2011-06-03

Prednisone
    Dosage: 215 milligram
    Start date: 2011-08-30
    End date: 2011-09-02

Prednisone
    Dosage: 225 milligram
    Start date: 2011-01-04
    End date: 2011-01-07

Prednisone
    Dosage: 215 milligram
    Start date: 2011-10-18
    End date: 2011-10-21

Prednisone
    Dosage: 60 milligram
    Administration route: Oral
    Start date: 2012-03-06

Prednisone
    Dosage: 230 milligram
    Start date: 2010-10-05
    End date: 2010-10-08

Prednisone
    Dosage: 230 milligram
    Start date: 2010-11-16
    End date: 2010-11-19

Prednisone
    Dosage: 225 milligram
    Start date: 2011-04-12
    End date: 2011-04-15

Thalidomide
    Dosage: 200 milligram
    Administration route: Oral
    Start date: 2010-10-12
    End date: 2010-11-29

Thalidomide
    Dosage: 200 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-08-24
    End date: 2010-09-06

Thalidomide
    Dosage: 100 milligram
    Administration route: Oral
    Start date: 2011-05-03
    End date: 2011-05-23

Thalidomide
    Dosage: 200 milligram
    Administration route: Oral
    Start date: 2010-12-07
    End date: 2011-05-02

Thalidomide
    Dosage: 200 milligram
    Administration route: Oral
    Start date: 2010-09-14
    End date: 2010-09-28

Thalidomide
    Dosage: 200 milligram
    Administration route: Oral
    Start date: 2010-10-05
    End date: 2010-10-10

Thalidomide
    Dosage: 50 milligram
    Administration route: Oral
    Start date: 2011-05-24
    End date: 2011-06-20

Other drugs received by patient: Furosemide; Furosemide; Potassium Chloride; Zometa; Colchicine; Colchicine; Darbepoetin Alfa-Albumin; Multi-Vitamins; Lorazepam; Glyburide; Furosemide; Potassium Chloride; Vicodin; Calcium Carbonate; Colchicine; Glipizide; Medrol; Ciprofloxacin HCL; Pregabalin; Metformin HCL; Equate Stool Softener; Gabapentin; Acyclovir; Glyburide; Zometa; Colchicine; Colchicine; Gabapentin; Neuremedy; Sodium Chloride; Furosemide; Warfarin Sodium; Metoprolol Tartrate; Lisinopril; Calcium Carbonate; Ativan; Gabapentin; Furosemide; Furosemide; Miralax; Gabapentin; Acyclovir; Furosemide; Furosemide; Acetaminophen; Calcium Carbonate; Fish OIL; Prochlorperazine Maleate; Influenza Vaccine



Possible Prednisone side effects in male

Reported by a individual with unspecified qualification from France on 2012-06-22

Patient: male, weighing 96.0 kg (211.2 pounds)

Reactions: Neuropathy Peripheral, Anaemia, Gait Disturbance, Asthenia, Lumbar Spinal Stenosis, Neuralgia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cellcept
    Indication: Renal Transplant
    Start date: 2010-12-18

Cellcept
    Start date: 2010-12-18

Cellcept

Cyclosporine
    Indication: Renal Transplant
    Start date: 2010-12-18

Cyclosporine
    Start date: 2010-12-18

Prednisone
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-12-18



Possible Prednisone side effects in female

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-06-12

Patient: female

Reactions: Anaemia, Urinary Tract Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: 14 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-01-19
    End date: 2012-01-22

Prednisone
    Dosage: 160 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-01-19
    End date: 2012-01-22

Thalidomide
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-01-19
    End date: 2012-01-29

Thalidomide
    Administration route: Oral
    Start date: 2012-02-07

Other drugs received by patient: Pantoprazole; Carbasalaat Calcium; Oxycontin; Oxynorm; Simvastatin; Acetaminophen; Diclofenac Sodium



Possible Prednisone side effects in female

Reported by a individual with unspecified qualification from United States on 2012-05-31

Patient: female, weighing 56.2 kg (123.6 pounds)

Reactions: Anaemia, Dehydration, Strongyloidiasis, Neutropenia, Thrombocytopenia, Enteritis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1148 mg

Doxorubicin Hydrochloride
    Dosage: 31 mg

Etoposide
    Dosage: 153 mg

Prednisone
    Dosage: 920 mg

Rituximab (Moab C2b8 Anti Cd20, Chimeric)
    Dosage: 630 mg

Vincristine Sulfate
    Dosage: 1.2 mg



Possible Prednisone side effects in 58 year old female

Reported by a physician from United States on 2012-05-24

Patient: 58 year old female, weighing 79.0 kg (173.8 pounds)

Reactions: Pancreatic Mass, Labyrinthitis, Contusion, Lung Infection, Blood Calcium Increased, Cyst, Hyperhidrosis, Balance Disorder, Back Pain, Splenic Artery Aneurysm, Metatarsalgia, Rhinitis, Stress, Rhinitis Allergic, Hepatic Cyst, Limb Injury, Tibia Fracture, Thyroid Neoplasm, Neuritis, Psoriatic Arthropathy, Bunion, Vestibular Neuronitis, Adverse Drug Reaction, Pulmonary Mass, Muscle Tightness, Fall, Foot Fracture, Muscle Strain, Rotator Cuff Syndrome, Malignant Melanoma, Depression, Acquired Claw TOE, Humerus Fracture, Radius Fracture, Device Failure, Syncope, Dupuytren's Contracture, Sinus Disorder, Heart Rate Increased, Hypothyroidism, Memory Impairment, Weight Decreased, Foot Deformity, Femur Fracture, Hand Fracture, Arthropathy, Sjogren's Syndrome, Cough, Anaemia Postoperative, Intervertebral Disc Protrusion, Cardiac Murmur, Hiatus Hernia, Pain in Extremity, Anaemia, Hyperglycaemia, Convulsion, Tendon Disorder, Insomnia, Stress Fracture, Haemangioma, Cardiovascular Disorder, Spinal Column Stenosis, Neuralgia, Dyslipidaemia, Nerve Root Injury Lumbar, Labile Hypertension, Wrist Fracture, Pain, Restless Legs Syndrome, Synovial Cyst, Adrenal Insufficiency, Intervertebral Disc Degeneration, Dizziness, Transient Ischaemic Attack, Gastrooesophageal Reflux Disease, RIB Fracture, Migraine, Nausea, Alanine Aminotransferase Increased, Urinary Tract Infection, Musculoskeletal Chest Pain, Blood Parathyroid Hormone Increased, Osteoarthritis, Anxiety, Renal Failure, Radiculitis, Vertigo, Arthritis, Metabolic Syndrome

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Alendronate Sodium
    Administration route: Oral
    Indication: Osteopenia
    Start date: 2008-04-01
    End date: 2010-08-01

Fosamax
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 1998-08-03
    End date: 2001-04-01

Fosamax
    Administration route: Oral
    Start date: 2010-01-01

Fosamax
    Administration route: Oral
    Start date: 2010-01-01

Fosamax
    Administration route: Oral
    Start date: 2001-04-01
    End date: 2008-03-01

Fosamax
    Administration route: Oral
    Indication: Osteopenia
    Start date: 2001-04-01
    End date: 2008-03-01

Prednisone
    Administration route: Oral
    Indication: Polymyalgia Rheumatica
    Start date: 1991-01-01

Reclast
    Start date: 2008-01-01
    End date: 2010-01-01



Possible Prednisone side effects in 44 year old female

Reported by a physician from Poland on 2012-05-23

Patient: 44 year old female

Reactions: Retroperitoneal Mass, Vomiting, Nausea, Folate Deficiency, Anaemia, Nephropathy Toxic, Iron Deficiency, Herpes Zoster, Vitamin B12 Increased, Asthenia, Beta 2 Microglobulin Increased, Leukopenia

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Ovarian Cancer

Doxorubicin HCL
    Indication: Ovarian Cancer

Prednisone
    Indication: Ovarian Cancer

Rituximab
    Indication: Ovarian Cancer

Vincristine
    Indication: Ovarian Cancer

Other drugs received by patient: Heviran; Tamoxifen Citrate



Possible Prednisone side effects in 80 year old male

Reported by a individual with unspecified qualification from France on 2012-05-21

Patient: 80 year old male

Reactions: Anaemia, Febrile Bone Marrow Aplasia, Bacterial Sepsis, Thrombocytopenia, Asthenia, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexchlopheniramine Maleate
    Dosage: 5 mg; iv;
    Indication: Premedication
    Start date: 2012-02-09
    End date: 2012-02-09

Jevtana KIT
    Dosage: iv, 35; iv
    Indication: Prostate Cancer Metastatic
    Start date: 2012-01-19
    End date: 2012-01-19

Jevtana KIT
    Dosage: iv, 35; iv
    Indication: Prostate Cancer Metastatic
    Start date: 2012-02-09
    End date: 2012-02-09

Methylprednisolone
    Dosage: 60 mg; iv;
    Start date: 2012-02-09
    End date: 2012-02-09

Prednisone
    Dosage: 5 mg; iv
    Indication: Premedication
    Start date: 2012-02-09
    End date: 2012-02-09

Ranitidine HCL
    Dosage: 50 mg;x1;iv
    Indication: Premedication
    Start date: 2012-02-09
    End date: 2012-02-09

Other drugs received by patient: Blood Products



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017